D.E. Shaw & Co’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.3M | Buy |
2,163,001
+173,493
| +9% | +$2.43M | 0.02% | 546 |
|
|
2025
Q1 | $31.1M | Sell |
1,989,508
-524,069
| -21% | -$8.2M | 0.03% | 494 |
|
|
2024
Q4 | $35M | Buy |
2,513,577
+768,553
| +44% | +$10.7M | 0.03% | 477 |
|
|
2024
Q3 | $16.2M | Buy |
1,745,024
+737,640
| +73% | +$6.86M | 0.01% | 742 |
|
|
2024
Q2 | $9.37M | Buy |
1,007,384
+790,518
| +365% | +$7.35M | 0.01% | 936 |
|
|
2024
Q1 | $2.15M | Buy |
+216,866
| New | +$2.15M | ﹤0.01% | 1733 |
|
|
2023
Q2 | – | Sell |
-10,629
| Closed | -$117K | – | 3081 |
|
|
2023
Q1 | $117K | Sell |
10,629
-26,547
| -71% | -$292K | ﹤0.01% | 2866 |
|
|
2022
Q4 | $550K | Sell |
37,176
-37,200
| -50% | -$551K | ﹤0.01% | 2684 |
|
|
2022
Q3 | $1.42M | Buy |
+74,376
| New | +$1.42M | ﹤0.01% | 2340 |
|
|
2020
Q3 | – | Sell |
-9,546
| Closed | -$289K | – | 2568 |
|
|
2020
Q2 | $289K | Buy |
+9,546
| New | +$289K | ﹤0.01% | 2350 |
|